Skip to main content
Caplight Logo









Kuano

Kuano

Private
CambridgeHealthcare & Life Scienceshttps://www.kuano.ai/

Last Round

Seed

Sep 12, 2023

Total Funding Raised

$3.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kuano is a drug discovery company that has developed a platform combining quantum mechanics and AI to design the next generation of medicines targeting enzymes.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Quantum Computing, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

AI drug discoveryenzyme inhibitorsquantum drug discoveryundruggable targetsdrug discovery platformquantum simulationde novo drug designphysics-informed AIenzyme transition statecomputational drug discoveryhit identificationin silico drug discoverylead optimizationgenerative chemistrypreclinical drug candidates

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kuano Comparables

Compare Kuano with similar companies based on industry and business-model similarity.

Kuano comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PolarisQB
88%
Qubit Pharmaceuticals
86%
Axiom Therapeutics
85%

Kuano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 12, 2023
SeedJul 8, 2021
Pre SeedFeb 25, 2021
AcceleratorJan 1, 2021

Key People

Founding team and executive leadership

David Wright

CTO Founder

Founding Team

Vid Stojevic

Co-Founder and CEO

Founding Team

Kuano Investors

Notable investors and investment history

Kuano investors
InvestorRounds
Ascension VenturesSeed
ACF InvestorsSeed
Cambridge AngelsPre Seed, Seed
o2h venturesSeed, Pre Seed
Meltwind AdvisorySeed, Pre Seed
Creative Destruction LabAccelerator
Mercia Asset ManagementSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 32% MoM, reaching 3.2K.

  • May 2, 2025

    Monthly visitors grew 366% MoM, from 537 to 2.5K.

Kuano Filings

Explore SEC and related filing metadata, where available.

Kuano filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kuano's valuation, stock price, and market status.

Is Kuano a public or private company?

Kuano is a private company.

What is the current stock price of Kuano?

Kuano is a private company with no public stock price. No recent secondary market data is available.

How much is Kuano worth (valuation)?

Valuation information for Kuano is not publicly available.

Can I buy Kuano stock?

Kuano shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kuano's last funding round?

Funding round information for Kuano is not publicly available.

Who are the main investors in Kuano?

Investor information for Kuano is not publicly disclosed.

Will Kuano IPO soon?

No public IPO plans have been announced for Kuano.

How can I track Kuano secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kuano's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range8
Year Founded2020
Last FundingSep 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?